{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:14:34Z","timestamp":1778742874490,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["KAKENHI 20509008"],"award-info":[{"award-number":["KAKENHI 20509008"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["KAKENHI 23500531"],"award-info":[{"award-number":["KAKENHI 23500531"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["KAKENHI 26282126"],"award-info":[{"award-number":["KAKENHI 26282126"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","award":["Heisei 21_25"],"award-info":[{"award-number":["Heisei 21_25"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00702-015-1431-3","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T14:23:36Z","timestamp":1438266216000},"page":"1593-1607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["A prospective study on blood A\u03b2 levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"122","author":[{"given":"Nobuya","family":"Kitaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Hiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigeru","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kushimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigehisa","family":"Koide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"1431_CR1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","volume":"27","author":"RD Bell","year":"2007","unstructured":"Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV (2007) Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27:909\u2013918","journal-title":"J Cereb Blood Flow Metab"},{"key":"1431_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","volume":"22","author":"M Boada","year":"2009","unstructured":"Boada M, Ortiz P, Anaya F, Hern\u00e1ndez I, Mu\u00f1oz J, N\u00fa\u00f1ez L, Olazar\u00e1n J, Roca I, Cuberas G, T\u00e1rraga L, Buendia M, Pla RP, Ferrer I, P\u00e1ez A (2009) Amyloid-targeted therapeutics in Alzheimer\u2019s disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization. Drug News Perspect 22:325\u2013326","journal-title":"Drug News Perspect"},{"key":"1431_CR3","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"98","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 98:8850\u20138855","journal-title":"Proc Natl Acad Sci USA"},{"key":"1431_CR4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"4","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol 4:405\u2013415","journal-title":"Acta Neuropathol"},{"key":"1431_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2003.11.024","volume":"15","author":"E Hellstr\u00f6m-Lindahl","year":"2004","unstructured":"Hellstr\u00f6m-Lindahl E, Mousavi M, Ravid R, Nordberg A (2004) Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer\u2019s patients. Neurobiol Dis 15:351\u2013360","journal-title":"Neurobiol Dis"},{"key":"1431_CR6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","volume":"38","author":"C Hock","year":"2003","unstructured":"Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, M\u00fcller-Tillmanns B, Lemke U, Henke K, Moritz E, Garcia E, Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A, Nitsch RM (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer\u2019s disease. Neuron 38:547\u2013554","journal-title":"Neuron"},{"key":"1431_CR7","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1523\/JNEUROSCI.3916-08.2008","volume":"28","author":"LW Hung","year":"2008","unstructured":"Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ (2008) Amyloid-b peptide (Ab) neurotoxicity is modulated by the rate of peptide aggregation: Ab dimers and trimers correlate with neurotoxicity. J Neurosci 28:11950\u201311958","journal-title":"J Neurosci"},{"key":"1431_CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2183\/pjab.90.353","volume":"90","author":"N Kaneko","year":"2014","unstructured":"Kaneko N, Nakamura A, Washimi Y, Kato T, Sakurai T, Arahata Y, Bundo M, Takeda A, Niida S, Ito K, Toba K, Tanaka K, Yanagisawa K (2014) Novel plasma biomarker surrogating cerebral amyloid deposition. Proc Jpn Acad Ser B Phys Biol Sci 90:353\u2013364","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"1431_CR9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00702-012-0844-5","volume":"12","author":"M Kato","year":"2012","unstructured":"Kato M, Kawaguchi K, Nakai S, Murakami K, Hori H, Ohashi A, Hiki Y, Ito S, Shimano Y, Suzuki N, Sugiyama S, Ogawa H, Kusimoto H, Mutoh T, Yuzawa Y, Kitaguchi N (2012) Potential therapeutic system for Alzheimer\u2019s disease: removal of blood Abs by hemodialyzers and its effect on the cognitive functions of renal-failure patients. J Neural Transm 12:1533\u20131544","journal-title":"J Neural Transm"},{"key":"1431_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10047-010-0482-3","volume":"13","author":"K Kawaguchi","year":"2010","unstructured":"Kawaguchi K, Kitaguchi N, Nakai S, Murakami K, Asakura K, Mutoh T, Fujita Y, Sugiyama S (2010) Novel therapeutic approach for Alzheimer\u2019s disease by removing amyloid-\u03b2 protein from the brain with an extracorporeal removal system. J Artif Organs 13:31\u201337","journal-title":"J Artif Organs"},{"key":"1431_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000322624","volume":"32","author":"N Kitaguchi","year":"2011","unstructured":"Kitaguchi N, Kawaguchi K, Nakai S, Murakami K, Ito S, Hoshino H, Hori H, Ohashi A, Shimano Y, Suzuki N, Yuzawa Y, Mutoh T, Sugiyama S (2011) Reduction of Alzheimer\u2019s Disease Amyloid-\u03b2 in plasma by hemodialysis and its relation to cognitive functions. Blood Purif 32:57\u201362","journal-title":"Blood Purif"},{"key":"1431_CR12","first-page":"91","volume":"18","author":"H Koumi","year":"2010","unstructured":"Koumi H, Maeda A, Yamamoto A, Kato Y, Okamura K, Sonoda K, Ando E, Kishikawa Y (2010) The sensitivity and specificity of Japanese version of the Mini-Mental Sate Examination. Bull Facul Soc Welfare Hanazono Univ 18:91\u201395","journal-title":"Bull Facul Soc Welfare Hanazono Univ"},{"key":"1431_CR13","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.271.8.4077","volume":"271","author":"YM Kuo","year":"1996","unstructured":"Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077\u20134081","journal-title":"J Biol Chem"},{"key":"1431_CR14","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","volume":"70","author":"OL Lopez","year":"2008","unstructured":"Lopez OL, Kuller LH, Mehta PD, Becker JT, Gach HM, Sweet RA, Chang YF, Tracy R, DeKosky ST (2008) Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study. Neurology 70:1664\u20131671","journal-title":"Neurology"},{"key":"1431_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","volume":"23","author":"Y Matsuoka","year":"2003","unstructured":"Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, Wang L, Casey E, Lu Y, Shiratori C, Lemere C, Duff K (2003) Novel therapeutic approach for the treatment of Alzheimer\u2019s disease by peripheral Administration of agents with an affinity to \u03b2-amyloid. J Neurosci 23:29\u201333","journal-title":"J Neurosci"},{"issue":"6012","key":"1431_CR16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774","journal-title":"Science"},{"key":"1431_CR17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/JCM.34.1.218-221.1996","volume":"34","author":"GM Megson","year":"1996","unstructured":"Megson GM, Stevens DA, Hamilton JR, Dennig DW (1996) d-mannitol in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. J Clin Microbiol 34:218\u2013221","journal-title":"J Clin Microbiol"},{"key":"1431_CR18","first-page":"1","volume":"6","author":"AWJ Morris","year":"2014","unstructured":"Morris AWJ, Carare RO, Schreiber S, Hawkes CA (2014) The cerebrovascular basement membrane: role in the clearance of \u03b2-amyloid and cerebral amyloid angiopathy, Front. Aging Neurosci 6:1\u20139","journal-title":"Aging Neurosci"},{"key":"1431_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-131802","volume":"40","author":"Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD, AIBL Research Group","year":"2014","unstructured":"Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD, AIBL Research Group (2014) Plasma amyloid-\u03b2 levels are significantly associated with a transition toward Alzheimer\u2019s disease as measured by cognitive decline and change in neocortical amyloid burden. J Alzheimers Dis 40:95\u2013104","journal-title":"J Alzheimers Dis"},{"key":"1431_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173\u2013177","journal-title":"Nature"},{"key":"1431_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.20508","volume":"58","author":"NS Schoonenboom","year":"2005","unstructured":"Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD (2005) Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? Ann Neurol 58:139\u2013142","journal-title":"Ann Neurol"},{"key":"1431_CR22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ (2001) Alzheimer\u2019s disease: genes, proteins, and therapy. Physiolo Rev 81:741\u2013766","journal-title":"Physiolo Rev"},{"issue":"4","key":"1431_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, Initiative Alzheimer\u2019s Disease Neuroimaging (2009) Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol 65(4):403\u2013413","journal-title":"Ann Neurol"},{"key":"1431_CR24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/NEN.0b013e3181c8ad2f","volume":"69","author":"GD Silverberg","year":"2010","unstructured":"Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE (2010) Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69:98\u2013108","journal-title":"J Neuropathol Exp Neurol"},{"key":"1431_CR25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539","journal-title":"Nature"},{"key":"1431_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, R\u00fcther E, Kornhuber J (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81:481\u2013496","journal-title":"J Neurochem"},{"key":"1431_CR27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1532-5415.2009.02670.x","volume":"58","author":"K Yaffe","year":"2010","unstructured":"Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, Cohen D, Anderson C, Appel L, Desalvo K, Ojo A, Seliger S, Robinson N, Makos G (2010) Chronic kidney disease and cognitive function in older adults: findings from the Chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 58:338\u2013345","journal-title":"J Am Geriatr Soc"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1431-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-015-1431-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1431-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T17:56:45Z","timestamp":1599415005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-015-1431-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1431"],"URL":"https:\/\/doi.org\/10.1007\/s00702-015-1431-3","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}